Reata Pharmaceuticals
RETA
$172.36
Share price
0.00%
Change (1 day)
373.78%
Change (1 year)
Categories
Operating Margin for Reata Pharmaceuticals (RETA)
Operating Margin as of May 2024 (TTM): -172.44%
According to Reata Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -172.44%. At the end of 2022 the company had an Operating Margin of -14,076.08%.
Operating Margin history for Reata Pharmaceuticals from 2015 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -14,076.08% | 443.03% |
| 2021 | -2,592.13% | -13.49% |
| 2020 | -2,996.33% | 173.83% |
| 2019 | -1,094.25% | 628.26% |
| 2018 | -150.25% | 51.48% |
| 2017 | -99.19% | 641.62% |
| 2016 | -13.37% | 2128.45% |
| 2015 | -0.60% | -108.5% |
| 2014 | 7.06% | -134.94% |
| 2013 | -20.21% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.